NCT04153487View on ClinicalTrials.gov

Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

July 16, 2021

Study Completion Date

July 16, 2021

Conditions
Acute Lung Injury, Transfusion Related
Interventions
DRUG

Ascorbic Acid Injectable Product

Intermittent Intravenous Infusion of Ascorbic Acid (Vitamin C) 2.5 gm / 6 hours for 96 hours

DRUG

Placebo

Placebo saline / 6 hours for 96 hours

Trial Locations (1)

22511

Damanhour University, Beheira

All Listed Sponsors
collaborator

Alexandria University

OTHER

lead

Damanhour University

OTHER

NCT04153487 - Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury | Biotech Hunter | Biotech Hunter